REGAIN Study

Uses

Where it comes from

Other

Highlighted claims

• The REGAIN study is a retrospective and prospective longitudinal observational asthma cohort. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study
• Asthma participants are followed for 18 months, while healthy controls are assessed only at baseline. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study
• The target enrollment was 780 asthma participants and 400 healthy controls. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study
• REGAIN aims to characterize asthma by treatment, control, inflammatory biology, molecular profile, and disease trajectory. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study
• The study combines prospective visits, electronic medical records, and serial biospecimen collection. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study
• The study was conducted at specialist asthma clinics in New York and Denver. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study